YS Biopharma announced it is changing its legal name from “YS Biopharma Co., Ltd.” to “LakeShore Biopharma Co., Ltd”. The name change and trading symbol change will not affect any rights of shareholders or the company’s operations and financial position. The company’s ordinary shares and warrants will continue to be listed on the Nasdaq. Effective with the opening of the trading day on May 28, 2024, the ticker symbol of the company’s ordinary shares and warrants will change from “YS” to “LSB” and from “YSBPW” to “LSBPW”, respectively. There is no action required by the company’s current shareholders with respect to the company name or ticker symbol changes. The company’s CUSIP will not change in connection with the name change.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on YS:
- YS Biopharma Approves Major Corporate Changes
- YS Biopharma granted additional 180 day extension by Nasdaq to regain compliance
- YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024
- YS Biopharma: YS-HBV-002 vaccine granted clinical trial approval by PFDA
- YS Biopharma’s PIKA Rabies Vaccine meets Phase 3 primary endpoints
Questions or Comments about the article? Write to editor@tipranks.com